Resveratrol as a Probable Multiheaded Treatment Approach for COVID-19.

Ahmadian, Roohollah; Biganeh, Hossein; Panahi, Yunes; Guest, Paul C; Jamialahmadi, Tannaz; Sahebkar, Amirhossein

Ahmadian, Roohollah; Biganeh, Hossein; Panahi, Yunes; Guest, Paul C; Jamialahmadi, Tannaz; Sahebkar, Amirhossein.

Ahmadian R; Student Research Committee, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Biganeh H; Faculty of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Panahi Y; Student Research Committee, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Guest PC; Faculty of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Jamialahmadi T; Pharmacotherapy Department, Faculty of Pharmacy, Baqiyatallah University of Medical Sciences, Tehran, Iran. yunespanahi@yahoo.com.
Sahebkar A; Laboratory of Neuroproteomics, Department of Biochemistry and Tissue Biology, Institute of Biology, University of Campinas (UNICAMP), Campinas, Brazil.

Adv Exp Med Biol ; 1328: 441-446, 2021.

Article in English | MEDLINE | ID: covidwho-1603321

ABSTRACT

ABSTRACT

The COVID-19 pandemic has plagued the world for more than 1 year now and has resulted in over 77 million cases and 1.7 million related deaths. While we await the rollout of the vaccines, new treatments are urgently needed to reduce the effects of this devastating virus. Here, we describe a number of preclinical studies which show promising effects of the polyphenol resveratrol.

Subject(s)

COVID-19; Humans; Pandemics; Resveratrol/therapeutic use; SARS-CoV-2

Keywords

COVID-19; Herbal medicine; Resveratrol

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Adv Exp Med Biol Year: 2021 Document Type: Article Affiliation country: 978-3-030-73234-9_29

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google